Stay updated with breaking news from Cato bioventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doubters about just how big and vibrant the Triangle's tech startup ecosystem has become over the past two decades could see plenty of proof at a venture capital event today in Durham. But there's a problem: It's sold out. ....
Cancer Advances, Inc. Announces Minisymposium Presentation at AACR DURHAM, N.C., April 08, 2021 (GLOBE NEWSWIRE) Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that its abstract entitled, “Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse model” has been selected for presentation in a minisymposium at the AACR Annual Meeting 2021. Jill Smith, MD of the Georgetown Lombardi Comprehensive Cancer Center, will present the results of this study during the week of April 10-15, 2021. The pre-recorded presentation will be available for viewing during the meeting. A live Q&A session will be held April 12, 1:30 pm EDT. In addition, attendees have the opportunity to contact Dr. Smith via a networking portal to discuss the research further. ....
Article content DURHAM, N.C., April 08, 2021 (GLOBE NEWSWIRE) Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that its abstract entitled, “Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse model” has been selected for presentation in a minisymposium at the AACR Annual Meeting 2021. Jill Smith, MD of the Georgetown Lombardi Comprehensive Cancer Center, will present the results of this study during the week of April 10-15, 2021. The pre-recorded presentation will be available for viewing during the meeting. A live Q&A session will be held April 12, 1:30 pm EDT. In addition, attendees have the opportunity to contact Dr. Smith via a networking portal to discuss the research further. ....